Publicacións (16) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

no ano 2022 Eliminar o filtro
filter_list Desde o ano 2022 Ata o ano 2022 Endocrinology

2022

  1. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

    Andrology, Vol. 10, Núm. 7, pp. 1328-1338

  2. Crosstalk between Melanin Concentrating Hormone and Endocrine Factors: Implications for Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  3. Downregulation of peripheral lipopolysaccharide binding protein impacts on perigonadal adipose tissue only in female mice

    Biomedicine and Pharmacotherapy, Vol. 151

  4. Factors associated with the optimum simultaneous control of diabetes, arterial hypertension and hypercholesterolemia in the diabetic population. BPC Diabetes study

    Semergen, Vol. 48, Núm. 4, pp. 225-234

  5. Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

    Journal of Biological Chemistry, Vol. 298, Núm. 5

  6. Human obese white adipose tissue sheds depot-specific extracellular vesicles and reveals candidate biomarkers for monitoring obesity and its comorbidities

    Translational Research, Vol. 239, pp. 85-102

  7. Impact of Enhanced Phagocytosis of Glycated Erythrocytes on Human Endothelial Cell Functions

    Cells, Vol. 11, Núm. 14

  8. Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

    Reviews in Endocrine and Metabolic Disorders, Vol. 23, Núm. 5, pp. 919-930

  9. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis

    Nature Communications, Vol. 13, Núm. 1

  10. Multidisciplinary consensus on nutritional and metabolic therapy in enhanced recovery after abdominal surgery programs: NutRICA Project

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 2, pp. 98-111

  11. Novel approaches to bone comorbidity in Cushing’s disease: an update

    Pituitary, Vol. 25, Núm. 5, pp. 754-759

  12. O-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease

    Frontiers in Endocrinology, Vol. 13

  13. Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  14. Reduced Levels of H2S in Diabetes-Associated Osteoarthritis Are Linked to Hyperglycaemia, Nrf-2/HO-1 Signalling Downregulation and Chondrocyte Dysfunction

    Antioxidants, Vol. 11, Núm. 4

  15. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

  16. Time above range for predicting the development of type 2 diabetes

    Frontiers in Public Health, Vol. 10